Aquestive Therapeutics Inc
(AQST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 11,078 | 13,287 | 15,345 | 11,122 | 7,149 |
| Cost of Goods | 3,366 | 4,400 | 4,466 | 2,757 | 2,788 |
| Gross Profit | 7,712 | 8,887 | 10,879 | 8,365 | 4,361 |
| Operating Expenses | 19,747 | 17,255 | 17,862 | 17,647 | 20,795 |
| Operating Income | -11,669 | -7,968 | -6,517 | -8,525 | -15,646 |
| Interest Expense | 3,589 | 6,554 | 6,223 | 6,095 | 4,726 |
| Other Income | -13,687 | -33 | 373 | -52 | 4 |
| Pre-tax Income | -28,945 | -14,555 | -12,367 | -14,672 | -20,368 |
| Net Income Continuous | -28,945 | -14,555 | -12,367 | -14,672 | -20,368 |
| Net Income | $-28,945 | $-14,555 | $-12,367 | $-14,672 | $-20,368 |
| EPS Basic Total Ops | -0.74 | -0.37 | -0.33 | -0.41 | -0.61 |
| EPS Basic Continuous Ops | -0.74 | -0.37 | -0.33 | -0.41 | -0.60 |
| EPS Diluted Total Ops | -0.74 | -0.37 | -0.33 | -0.41 | -0.61 |
| EPS Diluted Continuous Ops | -0.74 | -0.37 | -0.33 | -0.41 | -0.60 |
| EBITDA(a) | $-10,811 | $-6,016 | $-4,571 | $-6,586 | $-13,711 |